Kalbe Farma Tbk Stock Current Valuation
| PTKFY Stock | USD 17.29 3.76 17.86% |
Valuation analysis of Kalbe Farma Tbk helps investors to measure Kalbe Farma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Kalbe Farma's price fluctuation is not too volatile at this time. Calculation of the real value of Kalbe Farma Tbk is based on 3 months time horizon. Increasing Kalbe Farma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Kalbe Farma Tbk is useful when determining the fair value of the Kalbe pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Kalbe Farma. Since Kalbe Farma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kalbe Pink Sheet. However, Kalbe Farma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.29 | Real 18.23 | Hype 17.29 | Naive 17.26 |
The real value of Kalbe Pink Sheet, also known as its intrinsic value, is the underlying worth of Kalbe Farma Tbk Company, which is reflected in its stock price. It is based on Kalbe Farma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Kalbe Farma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kalbe Farma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kalbe Farma Tbk helps investors to forecast how Kalbe pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kalbe Farma more accurately as focusing exclusively on Kalbe Farma's fundamentals will not take into account other important factors: Kalbe Farma Tbk Company Current Valuation Analysis
Kalbe Farma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Kalbe Farma Current Valuation | 5.89 B |
Most of Kalbe Farma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kalbe Farma Tbk is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Kalbe Farma Tbk has a Current Valuation of 5.89 B. This is 59.02% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current valuation for all United States stocks is 64.6% higher than that of the company.
Kalbe Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kalbe Farma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kalbe Farma could also be used in its relative valuation, which is a method of valuing Kalbe Farma by comparing valuation metrics of similar companies.Kalbe Farma is currently under evaluation in current valuation category among related companies.
Kalbe Fundamentals
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.12 % | |||
| Current Valuation | 5.89 B | |||
| Shares Outstanding | 231.28 M | |||
| Price To Earning | 32.31 X | |||
| Price To Book | 4.75 X | |||
| Price To Sales | 3.28 X | |||
| Revenue | 26.26 T | |||
| Gross Profit | 11.11 T | |||
| EBITDA | 4.54 T | |||
| Net Income | 3.18 T | |||
| Cash And Equivalents | 189.29 M | |||
| Cash Per Share | 0.81 X | |||
| Total Debt | 490.28 B | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 4.08 X | |||
| Book Value Per Share | 4.20 X | |||
| Cash Flow From Operations | 2.83 T | |||
| Earnings Per Share | 0.96 X | |||
| Number Of Employees | 12.64 K | |||
| Beta | 0.32 | |||
| Market Capitalization | 7.21 B | |||
| Total Asset | 25.67 T | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 1.72 % | |||
| Net Asset | 25.67 T |
About Kalbe Farma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kalbe Farma Tbk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kalbe Farma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kalbe Farma Tbk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Kalbe Farma Tbk using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Kalbe Farma Tbk. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Kalbe Farma Tbk information on this page should be used as a complementary analysis to other Kalbe Farma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Kalbe Pink Sheet analysis
When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |